[New drug approval: Adjuvant Pembrolizumab in clear-cell renal-cell carcinoma at high risk for recurrence after nephrectomy].
作者信息
Brunet Maxime, Malouf Gabriel G
机构信息
Institut Bergonié, department of medical oncology, Bordeaux, France.
Strasbourg-Europe Cancer Institute (ICANS), department of medical oncology, Strasbourg, France; Inserm UMR_S1258, institute of genetics and of molecular and cellular biology, department of cancer and functional genomics, Illkirch, France.
出版信息
Bull Cancer. 2022 Sep;109(9):875-876. doi: 10.1016/j.bulcan.2022.05.005. Epub 2022 Jun 28.
PMID:35778302
Abstract
摘要
Zotero 插件